The real story is that per capita spending on the program, accounting for inflation and population growth, remains where it ...

Melbourne biotech Magellan Stem Cells is 17 years old and about to begin a pivotal Phase 3 trial of its stem cell treatment ...

A small Melbourne company founded by two medical researchers has landed one of Australia's biggest potential licensing deals.

Net spending on the Pharmaceutical Benefits Scheme rose by about $1.5 billion in 2025-26 as rebates paid by medicine ...

The current agreement between the Commonwealth and the research-based pharmaceutical industry promised faster access to new medicines through reforms to health technology assessment. Four years on, ...

Dr Brian McNamee AO will retire from CSL's board in March next year, and Gordon Naylor, who has served as Interim CEO and Managing Director since February, will become the company's chair.

The Department of Health, Disability and Ageing has committed significant resources to a Canberra consultancy to build a new "charging model" for assessing medicines, vaccines and medical devices for ...

The melanoma study's principal investigator, Professor Georgina Long of Melanoma Institute Australia, said the results ...

Uh Oh, We've Lost That Page! We're sorry... You'll probably be able to find what you want by visiting the Home page. We'll try not to let that happen again.

Chemist Warehouse keeps growing as Sigma sets its sights on oral GLP-1s October 21, 2026 - Latest News ...

Telix Pharmaceuticals has reaffirmed that it will pass US$1 billion in revenue and other income this year. Its third-quarter ...